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The preoperative assessment of the patient for neurosurgical and endovascular procedures involves the understanding of the
neurological disease and its systemic presentation, and the requirements of the procedure. There is a wide spectrum of diﬀerent
neurosurgical disorders and procedures. This article provides an overview of the preoperative evaluation of these patients with
respect to general principles of neuroanesthesia, and considerations for speciﬁc intracranial and vascular neurosurgical and
interventional neuroradiological procedures.
1.Introduction
The preoperative assessment of any patient is an integral
part of safe anesthesia practice. Neurosurgery covers a
wide spectrum of well-established procedures, but there are
also areas that are rapidity expanding such as functional
neurosurgery, awake craniotomy and interventional neuro-
radiology. The purpose of the preoperative assessment is for
the anesthesiologist to review the patient’s medical history
including the neurological events, to obtain an understand-
ing of the disease and its systemic manifestations, to ensure
optimization of all comorbidities, and to prepare and plan
for an appropriate and safe anesthetic. This article will
cover the general preoperative approach for neurosurgical
patients as well as considerations for speciﬁc intracranial and
vascular neurosurgical and interventional neuroradiology
procedures.
1.1. Preoperative Assessment. Neurosurgical patients vary
widely in their presentation, from an alert and coherent
patient presenting for an elective procedure to a patient with
depressed neurological status due a devastating neurological
insult for an emergent procedure. Hence, the diagnosis,
preoperative physical and detailed neurological status, and
the urgency of the procedure are important preoperative
considerations to formulate an appropriate anesthetic plan
[1]. The time and place of the preoperative interview will
vary; for an elective procedure this may be in an anesthesia
preoperative consult clinic several weeks before surgery, for
emergency procedures in the neurosurgical critical care unit.
In patients with a decreased level of consciousness, obtaining
of history and pertinent information may be challenging and
may only be obtainable from family members, caregivers, or
medical notes. Previous surgical procedures and anesthetic
notes oﬀer valuable information and should be included.
In addition to the routine assessment and preparation
of any preoperative patient, emphasis should be placed on
the review of the neurological system and comorbidities of
the disease and of the patient. A neurological history is
mandatory and should include the type and location of the
lesion, symptoms, and medications related to the neurolog-
ical problem, as well as the plan for treatment which may
involvebothsurgeryand/orendovasculartherapy.Questions
that will help illicit further information include a history
of seizures, neurological deﬁcits, signs and symptoms of
raised intracranial pressure (ICP) such as headaches, nausea,
vomiting, confusion, and a history of transient ischemic
attacks (TIA) or stroke. Neurological examination should
include the level of consciousness and the neurological
physicalexaminationwhichinvolves thestatusofthesensory
and motor systems and evaluation of cranial nerves.2 Anesthesiology Research and Practice
Preoperative cardiovascular disturbances are common in
patients undergoing neurosurgical interventions and include
blood pressure ﬂuctuations, electrocardiographic abnormal-
ities, arrhythmias, and myocardial ischemia or failure. They
can occur as consequences of central neurogenic eﬀects
on the myocardium and the autonomic nervous system
or concurrently associated medical conditions. Preexisting
cardiac disease should be identiﬁed, both symptomatic and
asymptomatic. The decision to perform further diagnostic
evaluations should follow established guidelines [2]. Mul-
tiple studies have reported improved outcome in patients
receiving perioperative beta blockers, however newer studies
have reported that perioperative beta blockers may not be
eﬀective if heart rate is not well controlled or in low risk
patients [3, 4]. In a recent retrospective review of patients for
noncardiac surgery, acute surgical anemia with a reduction
in hemoglobin greater than 35% from baseline increased
risks of cardiac complications in beta-blocked patients hence
suggesting that the transfusion triggers should be higher for
elective surgical patients on beta blockers [5]. The POISE
trial showed a signiﬁcant reduction in the primary outcome
of cardiovascular events and a 30% reduction in myocardial
infarction rates, but a signiﬁcant increase in 30 day stroke
and mortality [6]. The current ACC/AHA Guidelines on
the perioperative beta blocker administration advocates that
perioperative beta blockade should be used in patients on
beta blockers and those with positive stress test undergoing
major vascular surgery [7]. It also stresses that acute
administration of beta blockers without titration may be
harmful. Statins have been shown to improve perioperative
cardiac outcome, hence are continued in patients currently
taking them [7].
Review and optimizing of the respiratory system is
important to ensure adequate oxygenation and ventilation
intra and postoperatively. Patients with acute and chronic
pulmonary disease need to have their disease stabilized
preoperatively.Patientswithneurologicaldisordersmayhave
respiratory complications such as aspiration of gastric con-
tents and pneumonia, which can adversely aﬀect neurologic
outcome and survival. Neurogenic pulmonary edema may
occur in patients with brain injury, subarachnoid hemor-
rhage (SAH), and stroke. History of smoking and cessation
of smoking should be part of the preoperative evaluation
[8], though most studies have not been able to identify
preoperativesmokingasanindependentriskfactorformajor
cardiovascular events [9]. Smoking diminishes the measures
of cardiovascular function such as maximal exercise capacity
andendotheliummediatedvasodilatation,thusitisplausible
that even brief period of cessation may be of beneﬁt.
Cessation of cigarette smoking should ideally begin at least
6–8 weeks prior to surgery as this period of abstinence is
associated with improved pulmonary function and overall
perioperativemorbidity[10,11].Historyofobstructivesleep
apnea (OSA) may inﬂuence the intra and postoperative care
of the patient. There are speciﬁc groups of patients, such as
in acromegaly and Cushing’s disease, where there may be a
high incidence of OSA. Clinical symptoms include daytime
somnolence excessive snoring and fragmented night sleep.
The STOP questionnaire is a validated screening tool for
OSA [12]. Additional information on the body mass index,
age, neck circumference, and gender should also be sought
to increase the detection of the OSA patients [13]. The
incidence of perioperative adverse events is increased in OSA
patients [12].
Other medical disorders such as diabetes, renal impair-
ment, and hepatic disease will also aﬀect the anesthetic
management of the patient and need to be optimized. There
is an adverse association of hyperglycemia and neurosurgical
outcome [14]. In a prospective analysis, the initiation of
tight glycemic control reduced the mortality in neurosurgical
patients and other critically ill patients [15]. In patients
undergoing image-guided stereotactic brain biopsy, blood
glucoselevelslessthan200mg/dLwasassociatedwithalmost
a 100% positive predictive value of morbidity [16]. In
general, blood sugar should be monitored frequently with
the goal of avoidance of either hypo or hyperglycemia, and
the maintenance of sugar levels between 100mg/dL and
150mg/dL.
In the preoperative period neurosurgical patients often
present with rapid changes in intravascular volume precip-
itated by hemorrhage, dehydration, diuretics and mannitol
administration, and ﬂuid restriction. Fluid management
in the neurosurgical patient takes into consideration the
restoration of intravascular volume, the maintenance of
cerebral perfusion pressure and the avoidance of hyper-
glycemic and hypotonic ﬂuids [17]. Iso-osmolar solutions,
such as plasmalyte and 0.9% saline are used as they do
not change the plasma osmolality, and therefore do not
increase brain water content. Glucose-containing solutions
and hypo-osmolar solutions, such as lactated Ringer’s are
avoided as plasma osmolality is reduced, consequently brain
water content increases, worsening cerebral edema [18]. The
administrations of medications, such as mannitol, will need
to be carefully titrated in the presence of renal impairment
and congestive cardiac failure.
1.2. Preoperative Medications. All current ongoing medi-
cations and allergies need to be reviewed. The preoper-
ative continuation of most ongoing medications is usu-
ally straightforward but continuing of medications speciﬁc
for neurological disorders will depend on recommenda-
tions from the neurosurgeon or neurologist. Patients on
antiepileptic medications are known to have adverse eﬀects
from these medications as well as intraoperative pharma-
cokineticinteractions.Patientswhohavebeenplacedonpre-
operative dexamethasone may present with elevated blood
glucose levels which require careful monitoring [19, 20].
Patients with cerebral insuﬃciency may be on antiplatelet
agents or anticoagulants for treatment of acute stroke,
or secondary prevention of strokes from other disease as
with patients with cardiac disease including coronary artery
stents, prostatic heart valve, and intracardiac thrombus. The
decision to stop this therapy before surgery is controversial
and the planning should ideally be clariﬁed during the pre-
operative assessment [21, 22]. Consultation with specialists
such as hematologist, cardiologist and the surgeon is useful.
The risks and the beneﬁts of discontinuing or continuing
therapy should also be discussed with the patient and family.Anesthesiology Research and Practice 3
Factors to consider are the urgency of the procedure and the
presence of thrombotic or hemorrhagic risks. Recommenda-
tions for elective surgery with high hemorrhagic risk, such
as intracranial and spinal procedures and moderate to high
thrombotic risks suggest that aspirin should be continued,
but to withhold clopidogrel and if the neurological and
cardiovascular risks are low, the antiplatelet agents should be
withdrawn (7 days for aspirin, 10 days for clopidogrel and 14
days for ticlopidine) [22, 23]. Further consultation is needed
when major thrombotic factors exist such as when the time
interval from bare metal stent insertion is less than six weeks
or less than 12 months for patients with drug eluting stents.
Patients who are on anticoagulation with agents such as
warfarin need further consideration to determine the time
interval to stop its administration (4-5 days preoperatively)
and if anticoagulation with low molecular weight heparin
and/or unfractionated heparin is needed in the interval [21].
Additional preoperative coagulation proﬁle investigations
maybeneeded.Latexallergyhastobeexcludedfrompatients
who have had repetitive surgical procedures preformed, such
as for spinal biﬁda. Likewise an allergy to contrast medium
or protamine sulfate will have important considerations in
the patient undergoing radiological and endovascular proce-
dures. There are subgroups of disorders, where patients may
be on chronic pain medication necessitating the planning for
perioperative pain management.
The presence of preoperative anxiety is high among
neurosurgical patients. A recent study found that there
was an increased need for information, especially about
surgery, in patients with high levels of preoperative anxiety
[24]. Preoperative treatment with anxiolysis or opioids is
ac o n t r o v e r s i a ls u b j e c t[ 25]. Patients who have increased
ICP, or are obtunded are at a high risk of developing
respiratorydepressionandevenfurtherincreasesinICPwith
any sedation. Generally, for most neurosurgical patients with
intracranial disease, if any preoperative sedation is to be
used, it should be administered to the patient in a monitored
environment where its reversal and airway management can
be easy performed.
1.3. Physical Examination. Physical examination of the
patient needs to emphasize the neurological, as well as
the cardiac and respiratory systems. Documentation of the
assessment of neurological system is helpful for continued
patient care. This includes patient’s preoperative cognitive
function (level of consciousness, communication, and intel-
lect), and language (ability to communicate in written and
verbal form). The Glasgow Coma Scale (GCS) is a standard
means of assessment of the neurological state (Table 1)[ 26].
The GCS can assist the anesthesiologist in patient evaluation
and the urgency of the need of intubation and neurosurgical
intervention. A brief examination of the sensory and motor
function is needed with documentation of any deﬁcits,
such as a weakness or loss of sensation of the extremities.
Cranial nerve involvement or dysfunction can aﬀect patient
management during anesthesia. Occulomotor nerve controls
the pupillary size and response to light. Preoperative pupil
size should be documented for subsequent assessment of
anesthetic depth and for comparison with postoperative
Table 1: Glasgow Coma Scale.
Parameter Score
Eye opening
Spontaneously 4
To speech 3
To pain 2
None 1
Best verbal response
Orientated 5
Confused 4
Inappropriate words 3
Incomprehensible sounds 2
None 1
Best motor response
Obeys commands 6
Localizing pain 5
Withdraws from pain 4
Flexion to pain 3
Extension to pain 2
None 1
Patients with a scale score less than 7 require intubation for airway
protection.
pupil changes. The facial nerve can be damaged by face mask
ventilation, surgery, and positioning. A baseline evaluation
and documentation of any abnormality is appropriate prior
to induction of anesthesia. Stimulation of the glossopha-
ryngeal nerve by an oral airway or laryngoscope results in
severepainthatradiatestothejawandtheear.Thesepatients
can experience reﬂex bradycardia and hypotension during
painful episodes secondary to the aﬀerent discharge of the
glossopharyngeal nerve. The vagus nerve supplies motor
ﬁbers to the pharynx, palate, larynx and the trachea. Hoarse-
ness of the voice may indicate damage to the vocal cords.
The establishment of a preoperative blood pressure level
is helpful for intra- and postoperative decisions for appro-
priate blood pressure management [27, 28]. The presence
of cardiac abnormalities such heart murmurs, abnormal
heart rate and rhythm, poor peripheral pulses, signs of
cardiac failure and the presence of carotid bruit will require
further investigations and treatment. Respiratory system
examination involves the assessment of pulmonary function
andoftheairway.Anysignsofnewrespiratorydiseaseshould
be investigated and treated.
A thorough examination of the airway must be com-
pleted and documented using standard assessment guide-
lines [29]. The upper lip bite test has been shown to
have a high accuracy and speciﬁcity, when compared with
the thyomental distance, the inter incisor gap and the
sternomental distance and may be useful in patients with
restricted mouth opening and limited neck mobility [30].
Speciﬁc pathophysiological alterations, such as the presence
of raised ICP, SAH, acromegaly, and cervical spine disease,
will inﬂuence the technique chosen for securing of the
airway. The presence of a diﬃcult airway may further
add risk to intubation in these patients as hypoxemia4 Anesthesiology Research and Practice
and hypercarbia exacerbate secondary neurological injury.
Preoperative planning and discussion is required to ensure
that the safest technique(s) is chosen. Fibreoptic intubation
isnotuncommoninneurosurgery,with17%documentation
in a review of 1612 cases [31]. While there are multiple
factors that contribute to a diﬃcult airway, in neurosurgery
it is frequently seen in hypophyseal, craniofacial, and chronic
spine pathology.
1.4. Laboratory Investigations. The ASA practice advisory for
preanesthesia evaluation supports that routine preoperative
investigations should not ordered, but rather that the tests
should be selected based on type of procedure and the
accompanying co morbidities, for the purpose of guiding
and optimizing the preoperative management [32]. The test
results are usually acceptable for up to six months prior
to surgery provided the patient’s medical history has not
changed signiﬁcantly. Blood loss as a result of surgery is
common; one needs to ensure that there is an appropriate
cross match for blood transfusion for each procedure. Severe
anemia risks tissue hypoxia from impaired oxygen delivery.
In neurosurgical patients, hematocrit (Hct) of 30–33%
ensures optimal combination of oxygen carrying capacity
and viscosity [17]. Base line hemoglobin (Hb) is shown
to predict the need for subsequent transfusion in patients
undergoing surgical procedures associated with signiﬁcant
blood loss [33], hence can be used to aide in planning
perioperative transfusion. Theoretically coagulation tests
may detect a predisposition to perioperative hemorrhage,
however investigations of these tests show a low yield of
discovering unsuspected disease, and is not predictive of
perioperative hemorrhage if abnormal [34]. The preoper-
ative assessment is not complete without the review of
neuroradiological images such as the computer tomography
(CT), magnetic resonance imaging (MRI), and angiography.
Valuable information pertaining to the size of the lesion, its
location,possiblevascularity,andthesurroundingstructures
can be obtained.
1.5. Communication. Preoperative assessment also includes
a thorough discussion with the patient and family of
the techniques of anesthesia, requirements for the speciﬁc
procedure such as invasive monitoring, the risks associated
with anesthesia and with the patient’s medical comor-
bidities, and the plans for the postoperative care, such
as postoperative ventilation and pain management. Some
procedures are performed as day surgery and the assessment
of the ability of the patient and family to do this, plus
instructions need to be clariﬁed during their preoperative
interview [35]. Appropriate instructions are given with
respect to preoperative medications and fasting. The actual
procedureforobtainingconsentforanesthesia/surgeryvaries
amongst institutions. This can be diﬃcult and challenging
in neurosurgical patients, as some will have depressed
levels of consciousness, or diminished capacity to com-
prehend. Appropriate institutional procedures need to be
followed. Finally, but perhaps the most important aspect
of preoperative preparation is the communication with
the surgeon and/or neuroradiologist. Pertinent information
suchastheurgencyandpossiblediﬃcultiesoftheprocedure,
positioning,useofintraoperativeneurologicmonitoringand
theplanforpostoperativecarehelpsinthepreparationofthe
patient.
2.SupratentorialIntracranialTumors
The presentation of the patient with a supratentorial tumor
will vary depending on the type of tumor, its location and
size, and proximity to vital structures. The documentation
of any altered level of consciousness, signs, and symptoms of
raised ICP, sensory or motor deﬁcits and seizures is essential.
Tumors operated upon are usually meningiomas, gliomas,
ventricular colloidal cysts or basal cistern epidermoids.
Meningiomas can be technically demanding operation and
is often associated with signiﬁcant blood loss, while gliomas
often undergo debulking with little risk of bleeding. It is
also useful to review the CT and MRI imaging to ascertain
characteristicsofthetumorsuchasvascularity,size,location,
and its proximity to a sinus and presence of increased ICP.
Otheraspectstoevaluatearethehydrationandvolumestatus
of the patient, especially those scheduled for emergency
surgery. This can be assessed in terms of ﬂuid intake, history
of nausea and vomiting, diuresis with mannitol therapy for
increased ICP, and the presence of inappropriate secretion
of anti diuretic hormone syndrome (SIADH), or cerebral
salt wasting. Preoperative management of the electrolyte
imbalances may be needed. For patients who receive pre-
operative steroids, dexamethasone, and antiepileptic such as
phenytoin or fosphenytoin, the drugs should be continued
preoperatively. Dexamethasone will reduce tumor cerebral
edema and this often leads to substantial symptomatic relief
[36]. However, its use is associated with an increase in blood
glucose levels [19, 20]. The administration of premedication
for sedation can be risking in this group of patients. If
respiratory depression results with increasing hypercarbia,
there may a marked elevation in ICP in patients who have
been well compensated when fully awake.
3. Awake Craniotomy for Tumor Surgery
Awake craniotomy for tumor surgery is often used when the
lesion is adjacent to eloquent cortex, such as speech or motor
function [37]. Beneﬁts of awake craniotomy include better
preservation of eloquent function; shorter hospitalization
and therefore reduction in cost [38]. These procedures
require careful patient selection as part of preoperative
preparation. Patients with anxiety disorders, claustrophobia,
low tolerance to pain, and psychiatric disorders are not
alwayssuitablecandidatesforthisprocedureaspatientcoop-
eration and understanding are factors that ensure success to
the procedure. The degree of anxiousness, tolerance to pain
and the ability to cooperate are factors to be noted during
the preoperative assessment. Choosing an awake technique
depends on several other factors other than patient’s physio-
logical proﬁle, such as location of the lesion, the presence of
obstructive sleep apnea, seizures and nausea and vomitingAnesthesiology Research and Practice 5
[39]. Based on the clinical symptoms, signs, and imaging,
evaluation of the degree of intracranial hypertension is
documented. The hemorrhagic risk of the procedure is
determined depending on the type of lesion and procedure.
There are diﬀerent techniques of awake craniotomy, such
as asleep-awake-asleep or monitored anesthesia care with
conscious sedation. With each technique, airway assessment
is of extreme importance, predictors of diﬃcult airway and
factors that can favor upper airway obstruction such as obe-
sity and OSA should be noted as the anesthesiologist must
plan for possible emergent manipulation of the airway in a
diﬃcult position [29]. Preparation of the patient includes
psychological preparation, reassurance and educating the
patient regarding the events of the procedure including
various tests during mapping.
4. PituitaryTumor
Tumors of the pituitary gland are heterogeneous. Anes-
thetic care requires an understanding of the complex
pathophysiology secondary to the patient’s dysfunction of
their endocrine system [40]. Pituitary tumors are classiﬁed
according to size at time of diagnosis: microadenomas are
less than 1cm in diameter, macroadenomas are greater than
1cm and their function: secreting, nonsecreting. Patient’s
symptoms will vary depending on the type of hormones
secreted, the size and possible mass eﬀect of the tumor
(Table 2). Nonfunctioning tumors are more likely to be
macroadenomas and to present with compressive symptoms
such as headaches and visual changes. Medical evaluation
is undertaken to optimize comorbidities associated with the
speciﬁcendocrinedysfunction.Patientswithacromegalyand
Cushing’s disease have unique systemic manifestations [40].
With acromegaly, there are multiple changes in the patients’
physical structure which will impact on anesthesia, such as
t h el a r g eb o d ym a s sa sw e l la sa nu n p r e d i c t a b l ea n dd i ﬃcult
airway and OSA [41]. Detailed evaluation of the cardiac
system is needed, as this may be a cause of morbidity and
mortality [41, 42]. Patients with Cushing’s disease present
with multiple medical issues such as hypertension, glucose
intolerance, myelopathy, osteoporosis, obesity, and OSA.
Features such as obesity, moon facieses, buﬀalo hump and
OSA may be associated with a diﬃcult airway [43, 44].
Additional laboratory investigations are directed towards
detecting endocrine and electrolyte abnormalities. Sodium
imbalances may indicate posterior pituitary dysfunction in
the form of diabetes insipidus or SIADH (Table 3). All
endocrinerelatedmedicationsneedtobecontinued.Patients
with preoperative hypopituitarism should receive steroid
and hormone replacement therapy perioperatively [45, 46].
Drug administration and therapy is guided by laboratory
investigations and is often overseen by an endocrinologist.
5. Posterior Fossa Surgery
Posterior fossa surgery provides unique concerns and pro-
blems for the anesthesiologist. Patients may present various
symptoms such as dysphagia, loss of gag reﬂex, laryngeal
Table 2: Pituitary tumors and frequency of occurrence.
Pituitary tumor Hormone secreted Frequency of
occurrence
Prolactinoma Prolactin 20–30%
Cushing’s
disease
Adenocorticotropic
hormone 10–15%
Acromegaly Growth Hormone 5–10%
Gonadotroph
Follicle stimulating
Hormone/Lutenising
hormone
5%
Thyrotropic Thyroid Stimulating
Hormone <3%
Mixed cell
adenoma None 20–30%
Nonfunctioning
adenomas None 20%
nerve dysfunction, and altered states of consciousness.
Preoperative documentation of these is important for assess-
ment of the neurological status at emergence and for
planning of postoperative care. Patients with a diminished
gag reﬂex may require continued intubation postoperatively.
Positioning is more complicated and may be park bench,
proneorsitting.Inthelateralandpronepositionpatientsare
at increased risk for peripheral nerve injury, eye injury and
postoperative blindness [47]. Review of possible risk factors
for these complications should be considered. In the sitting
position there are increased risks of quadriplegia, paraplegia,
facial edema, macroglossia, and venous air embolism (VAE).
The incidence of VAE is high (39%) in the sitting position
[48]. Preoperatively one needs to rule out the presence of
an intracardiac (persistent foramen ovale) or an intrapul-
monary shunt [49]. Transesophageal echocardiography and
transcranial Doppler ultrasound are used to assess for a per-
sistent foramen ovale [50, 51]. The presence of a persistent
foramen ovale is an absolute contraindication to the sitting
position. Relative contraindications include atherosclerotic
cardiovascular disease, hemodynamic instability, and severe
cervical canal stenosis. Patients with chronic pain from
cranial nerve disorders such as trigeminal neuralgia present
f o rp r o c e d u r e ss u c ha sr h i z o t o m ya n di n j e c t i o no fg l y c e r o l
or microvascular decompression. The major preoperative
consideration of this group of patients is their use of chronic
pain medication.
6. Cerebral Aneurysm
The extent of the preoperative assessment of a patient with
a cerebral aneurysm will be determined by their clinical pre-
sentation. Patients with intact aneurysms may be completely
asymptomatic, in contrast to the patient with an acute SAH
[52]. The neurological assessment of the patient with SAH
should include the a grading such as World Federation of
Neurosurgical Surgeons and GCS, and location, size, and
number of aneurysms. Many multisystem manifestations
may occur after a SAH. Intracranial complications include
rebleeding, vasospasm, hydrocephalus, clot, and seizures.6 Anesthesiology Research and Practice
Table 3: Diﬀerences between diabetes insipidus and syndrome of inappropriate antidiuretic hormone.
Diabetes insipidus Syndrome of inappropriate
antidiuretic hormone
Presentation Polyuria Thirst (awake patients) Hyponateriamia
Serum sodium Increased >145mEq/L Decreased <135mEq/L
Serum osmolarity High >310mOsm/L Low/hypotonic <275mOsm/L
Urine volume Increased volume >4L/day Low
Treatment Supportive ﬂuid replacement and
DDAVP
Fluid restriction with hypertonic sodium
correction if serum sodium <120mEq/L
Cardiac complications include abnormalities in rhythm and
electrocardiographic changes, elevated cardiac enzymes, and
myocardial dysfunction [53–55]. Neurogenic pulmonary
edema can occur at time of cerebral insult or up to two
weeks after SAH [56] .T h e r em a yb ec o n t r o v e r s ya st ob e s t
patientmanagementwhencardiacabnormalitiesarepresent,
that is, whether to delay surgery for cardiac investigations.
The decision to proceed with surgery needs to be balanced
with the risk of rebleeding and needs to be discussed
with the surgeon or radiologist. Electrolyte abnormalities
including hyponatremia, hypokalemia, hypomagnesaemia
and hypocalcaemia may be encountered and will need pre-
operative correction. Review of radiological imaging helps to
determine the extent of the bleed, size and location of the
aneurysm. Some patients present with cerebral vasospasm
and are treated with “triple H therapy” (induced hyper-
tension, hypervolemia, and hemodilution). Hypervolemia,
especially in patients with a poor cardiac reserve, can result
in pulmonary edema. Most patients are started on a calcium
blocker, usually nimodipine, and this should be continued
preoperatively. Communication is essential with the surgeon
regarding patient positioning, likelihood of temporary clip
application, and need for hemodynamic manipulations and
cerebral protection.
7. Cerebral Arteriovenous Malformation
Patients with an AVM present with an SAH, neurological
deﬁcits, seizures, headaches or may be completely asymp-
tomatic. A cerebral aneurysm may also be associated with
theAVM.Manyoftheanestheticissuesinvolvedintreatment
of cerebral aneurysms are also applicable to the AVM group.
The important consideration in surgical AVM resection is
attentiveness to perioperative blood pressure management.
Induced hypotension is frequently used intraoperatively to
reduce bleeding and postoperatively strict control of the
blood pressure is often needed to minimize complications
such as bleeding and hyperperfusion syndrome [57]. Avail-
ability of blood for transfusion is essential, as blood loss can
be substantial during the surgical resection.
8. CarotidArteryStenosis
Patients scheduled for a carotid endarterectomy can present
with TIA, completed stroke or may be asymptomatic.
Common symptoms include changes in vision (amaurosis
fugax), speech, or weakness of the extremities. Physical
examination may reveal a high pitch bruit at the origin of
the internal carotid artery, changes in the retina, sensory,
and motor deﬁcits. Radiological imaging (MRI or CT
angiography, Doppler ultrasound or angiography) should be
reviewed. The occurrence of bilateral carotid artery disease
should be noted. Preoperative evaluation needs to emphasize
the neurological system but also the cardiac system, as
the risk of myocardial ischemia is similar to the risk of
neurological injury postoperatively [58, 59]. The history,
physical examination, and investigations employed should
focus on the identiﬁcation of angina, myocardial infarction,
congestive cardiac failure and the presence of arrhythmias.
Hypertension is a treatable and preventable risk factor for
the development of stroke as the incidence of postoperative
neurological deﬁcits is greater in patients with uncontrolled
preoperative hypertension [59]. McCroy et al. reported in a
multicenter trial that the diastolic pressure of >110mmHg
was a predictor of adverse outcome [60]. Hence there may
be reason to delay elective surgery if the preoperative blood
pressure is greater than 180/110mmHg [61]. The question
of the extent of cardiac investigations in each patient is
debatable and one should use established guidelines [62].
Other risk factors include diabetes, hypercholesterolemia,
peripheral vascular disease and chronic obstructive pul-
monary disease [63]. Cigarette smoking has been identiﬁed
as a risk factor for carotid restenosis [8]. Control of
blood glucose levels is needed, as there may be a negative
relationship between plasma glucose and outcome after
stroke [64, 65], however data suggests that surgery can be
performed safely in patients with diabetes [65, 66]. History
of cervical arthritis and appearance of TIA symptoms with
certain head and neck positions should be noted, to avoid
precipitating cerebral ischemia during intraoperative head
positioning. Most patients with carotid artery stenosis will
be on some form of antiplatelet therapy or anti coagulation.
Though these drugs may impair coagulation, there is not
a consensus as when or if they should be stopped prior to
surgery. The Cochrane review concluded that antiplatelet
drugs can reduce the risks of stroke in patients undergoing
CEA, while they may increase the risk of hemorrhage
[67]. There were too few data to quantify the eﬀect, and
hence the recommendation supported the routine use of
antiplatelet drugs in patients having CEA [67]. This decisionAnesthesiology Research and Practice 7
needs to be made in conjunction with the neurosurgeon or
neurologist.
9.Extracranial-IntracranialBypassSurgery
Extracranial-intracranial (ECIC) bypass surgery is per-
formed for cerebral revascularization in patients with history
of cerebral ischemia such as patients with cerebral vascular
occlusive disease and moyamoya, and for replacement of
blood ﬂow where sacriﬁce of a vessel is required dur-
ing complex aneurysm or tumor surgery [68, 69]. The
preoperative assessment requires careful review of their
neurological system as many will present with TIA or stroke.
Comorbidities may include other systemic disorders that
are associated with moyamoya such as sickle cell disease.
Intraoperative factors that may aggravate cerebral ischemia
include hypotension, hypoxemia, hypovolemia, anemia, and
hyperglycemia. The patient should be optimized to prevent
these. Blood pressure manipulation is frequently required
especially during temporary occlusion of a cerebral artery,
thus preoperative blood pressure assessment and documen-
tation is critical.
10. Interventional Neuroradiology
The endovascular treatment of many neurosurgical patients
includes the coiling and stenting of aneurysms, embolisation
of AVM, arteriovenous ﬁstula, and vascular tumors, and
stenting of carotid artery stenosis [70]. The anesthetic
considerations in this group of patients include mainte-
nance of physiological stability, manipulation of systemic
and regional blood ﬂow, managing anticoagulation, and
associated complications. Assessment and preparation of
these patients also involves ensuring that they are suitable
for radiological procedures. Pregnancy should be excluded
in the child bearing age group. Renal function should be
noted as contrast medium employed during imaging can
worsen preexisting renal insuﬃciency [71]. Documentation
of patients’ history of adverse reaction to contrast dyes
requires pretreatment with steroids and anti histamines
[72]. Coagulation status of the patient as well as a history
of allergy to protamine sulphate needs documentation as
anticoagulation is employed during these procedures. As the
radiology suite may be remote from the main operating
rooms any possible diﬃculties during anesthesia should
be noted to allow for preparation by the anesthesiologist.
This includes patients with signiﬁcant or unstable cardiac
and respiratory disease, a diﬃcult airway or a patient who
requires additional monitoring not routinely available in
the radiology suite. A careful airway assessment should
include attention to the history of snoring as the resul-
tant movement artifact distorts the quality of the images
when the patient is awake or sedated. Most endovascular
procedures can be performed with general anesthesia or
conscious sedation techniques. Frequently general anesthesia
is preferred to ensure an immobile patient for good imaging
and less chance of rupture of vessels or lesion. Discussion
of the anesthetic management with the patient needs to
include the technique of anesthesia and if awake they need
reassuranceandinformationaboutwhattoexpectduringthe
procedure.
Endovascular therapy with the use of coils and stents is
an accepted mode of treatment of many cerebral aneurysms,
though there is controversy [73]. The preoperative con-
cerns and preparations are the same as for the surgical
treatment of the aneurysms. If endovascular treatment is
not successful many of these patients will then undergo
surgery. Embolization of an AVM is performed as a com-
plete treatment modality especially when the AVM is not
suitable for surgical resection due to diﬃcult anatomical
access or location. A preoperative embolization may be
performed for large AVM to minimize intraoperative blood
loss. Attention to the preoperative base line blood pressure
is important as manipulation of hemodynamics includes
induced hypotension and even the use of adenosine to
stop the heart during delivery of the embolic materials.
Carotid artery stenting is a reasonable alternative, to carotid
endarterectomy, particularly in patients at high-risk [74].
These patients may have diﬃcult surgical anatomy, but
more concerning to the anesthesiologist are the medical co
morbidities. The preoperative assessment in the high risk
patient will require a multidisciplinary approach to optimize
areas of physiological concerns such as blood pressure,
heart rate, oxygenation, and hemoglobin. Most frequently
these procedures are performed with conscious sedation
and careful monitoring of the cardiac and neurological
systems [75]. Documentation of the baseline heart rate
during the preoperative assessment is important as severe
bradycardia and asystole can be anticipated during this
procedure, especially during balloon inﬂation. Patients with
elevated systolic blood pressures are at an increase risk
of hemodynamic instability and neurological events during
stent application [76].
11. FunctionalNeurosurgery:
DeepBrainStimulators
Functional neurosurgery with the use of deep brain stimu-
lators (DBS) began and was initially successful in patients
withParkinson’sdisease.Itsapplicationshavesinceexpanded
to treat disorders such as dystonia, tremors, epilepsy, and
chronic pain. The preferred technique of anesthetic man-
agement in many centers is local anesthesia with monitored
care [77]. However both conscious sedation and general
anesthesia are also used. Meticulous preoperative assessment
isneededtooptimizethispopulationofoftenelderlypatients
with multiple comorbidities. The patients should be assessed
fortheirabilitytocooperateandabilitytotoleratethevarious
stages of this surgery which include placement of a head
frame, preoperative imaging, and the insertion and testing
of the DBS. As MRI is often performed prior to the DBS lead
implantation, meticulous history of pacemakers, aneurysm
clips or implanted ferrous metal should be obtained.
Contraindication to DBS includes patient non compliance,
dementia, medical co morbidities that preclude safe surgery,
and extensive brain atrophy. Assessment of the airway is
criticalespeciallyfortheawakepatientsasaﬁxedheadframe,
which is secured to the operating room table is used, making8 Anesthesiology Research and Practice
Table 4: Systemic eﬀects of Parkinson’s disease.
System Clinical signs/symptoms Relevant investigations
Central nervous system
Muscle rigidity, Tremors,
Depression, Hallucination,
Akinesia
Neurological assessment
Psychological assessment
Autonomic nervous system
Diﬃculty or alteration in
salivation, Gastrointestinal
function, Temperature
regulation, Seborrhoea
Gastrointestinal studies
Cardiovascular system Hypertension, Arrhythmias,
Orthostatic hypotension
Electrocardiogram,
Echocardiogram
Respiratory system
Retained secretions, Atelectasis,
Respiratory Infections,
Aspiration Pneumonia
Chest radiograph, Arterial blood
gases, Spirometry, Pulmonary
function test
Gastrointestinal system
Dysphagia, Sialorrhoea,
Esophageal dysfunction, Weight
loss
Serum albumin, electrolytes,
creatinine
Endocrine system Altered glucose metabolism Blood glucose level
Table 5: Medical therapy for Parkinson’s disease.
Drugs Side eﬀects
Dopamine agonist
Bromocriptine,
Carbegoline,
Nausea/vomiting,
Ramipraxole, Ropinirole Delusions/hallucinations,
Hypotension, Dysrhythmias
Dopamine precursors
Levodopa, Carbidopa,
Sinemet
Similar to Dopamine Agonist
Anticholinergics
Benzotropine Confusion/hallucination,
Sedation/drowsiness, Dry mouth,
Urinary retention
MAOI-B inhibitors
Selegiline Diarrhea
emergent manipulation of the airway diﬃcult [78]. Preop-
erative preparation includes instruction and reassurance of
the patient for the requirements of procedures. Medications
used to treat motor symptoms are often withheld on the
morning of the surgery. Premedications such as opiods,
benzodiazepines, and other sedatives can interfere with the
interpretation of tremor and hence is avoided. The decision
to preoperatively withhold anti Parkinson drugs may result
in a patient with severe symptoms of rigidity or tremors.
Patients with Parkinson’s disease are often elderly with
a classic triad of resting tremor, muscle rigidity, and
bradykinesia with loss of postural reﬂexes [79] and multi-
system problems (Table 4). There are also the potential drug
interactions and adverse reactions from anti-Parkinson’s
medications (Table 5)[ 78].
12. Epilepsy Surgery
Patients with intractable epilepsy not controlled with med-
ical therapy are candidates for surgical resection of their
seizure foci [80]. A number of diﬀerent procedures requiring
anesthesia are performed during the investigations and
treatment. This includes insertion of cortical electrodes
for mapping and activation of the epileptogenic focus,
and craniotomy for resection of the focus that may be
with awake craniotomy or under general anesthesia, with
or without electrocorticography and stimulation testing
[81]. Communication among all team members, including
neurologist, surgeon, and anesthesiologist, is vital to the
successful preparation of these patients for the chosen
technique of anesthesia. The administration of anticon-
vulsant agents prior to surgery is done in consultation
with the neurologist and surgeon. Speciﬁc concerns of
patients with epilepsy include the accompanying medical
problems such as psychiatric disorders, neuroﬁbromatosis,
and multiple endocrine adenomatosis. Speciﬁc anesthetic
considerations include adverse eﬀects of antiepileptic drugs
such as confusion, sedation, ataxia and nausea and vomiting.
Most anticonvulsants are metabolized in the liver and lead to
induction of liver enzymes that increase the metabolism of
other drugs, particularly anesthetics. Other side eﬀects from
drugs include depresses the hemopoietic system and cardiac
toxicity.Long-termtreatmentwithphenytoincausesgingival
hyperplasia with poor dentition and potentially diﬃcult
airway management.
13. Summary
Anesthesia for the patient undergoing a neurosurgical and
endovascular procedure presents special considerations. The
brain is a highly vascular organ enclosed within a rigid skull.
Tolerance of the brain to disruption of substrate delivery is
minimal.AnestheticandphysiologicalparameterscontrolledAnesthesiology Research and Practice 9
by the anesthesiologist have profound eﬀects on the cerebral
homeostasis. The appropriate preoperative evaluation and
preparation of the patient is critical to the success of
the outcome. An understanding of the pathophysiological
disturbances, the systemic manifestations associated with
the disease state, the procedure and its special requirements
form the essence of a through preoperative assessment.
Communication with the patient and family, as well as
the neurosurgeon and neuroradiologist, will ensure a good
understanding of the anticipated events and allow for a well-
prepared patient.
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